gut microbiota

Bacterial signatures in gut and airway may be biomarker for COVID-19 severity

The findings of a new research suggest that changes in the microbial composition of people with COVID-19 could be used as a biomarker of invasion of lung pathogens and dysbiosis…

Gut-Brain Theory – Episode 2: The link between gut and depression

Together with Prof. Ted Dinan (UCC Ireland), in this episode we discuss the link between gut and depression.

Niall Hyland: ‘Challenges to unlocking the real potential of gut brain axis’

Niall Hyland (University College Cork) discussed the research on gut brain axis and the potential role of psychobiotics.

IgA antibodies bind to specific gut bacteria in mice

The findings of a new research may inform strategies for treating intestinal diseases by targeting pathogens without killing beneficial gut bacteria.

Some gut bacteria produce key lipids involved in cell signaling

The findings of a recent study suggest that the production of inositol lipids is common in Bacteroidetes and other gut-associated bacteria, and it may be a means of cross-kingdom communication.

Seed Health and Axial Therapeutics Collaborate to Translate Research into Probiotic Innovations for Neuropsychiatric Health

The partnership program aims to develop next-generation probiotics and therapeutics to modulate the gut microbiota to target areas like anxiety, depression and mental well-being.

Structures of microbial enzymes hint at how these proteins recognize their targets

New research offers insights into how human gut bacteria recognize sulfated glycans. The findings could help to develop interventions for diseases where sulfated glycan metabolism is altered.

Microbiotas of Hadza infants differ from those of infants living in industrialized areas

New research shows that microbiota diversity appears early in infants from nonindustrial populations and could be traced back to their mothers as well as to the local environment. 

Boehringer Expands BiomX Collaboration to Discover IBD Microbiome Biomarkers

It's the second agreement between Boehringer Ingelheim and BiomX focused on IBD. The first one in 2020.

Similar gut bacteria may influence different gastrointestinal diseases

Researchers have found that some microbes involved in inflammatory conditions produced different effects based on their interaction with different host genes and through different pathways.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top